πŸ‡ΊπŸ‡Έ FDA
Patent

US 9950059

Immunogenic composition

granted A61KA61K2039/525A61K2039/552

Quick answer

US patent 9950059 (Immunogenic composition) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/525, A61K2039/552, A61K39/12, A61K39/17